Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perspective TherapeuticsFRA:AAJ0 -9.08%33 Market Cap is €299.44 Mil as of Jul. 18, 2026. GuruFocus rates FRA:AAJ0 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Perspective Therapeutics ranks better than 63.74% on this metric.
Perspective Therapeutics's quarterly market cap
declined
from Sep. 2025 (€203.69 Mil) to Dec. 2025 (€165.03 Mil) but then
increased
from Dec. 2025 (€165.03 Mil) to Mar. 2026 (€371.70 Mil).
Perspective Therapeutics's annual market cap
increased
from Jun. 2022 (€38.52 Mil) to Dec. 2023 (€114.41 Mil) and
increased
from Dec. 2023 (€114.41 Mil) to Dec. 2024 (€202.12 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Perspective Therapeutics's Enterprise Value for Today is €65.24 Mil.
Perspective Therapeutics (FRA:AAJ0) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Perspective Therapeutics Market Cap Related Terms
Perspective Therapeutics Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Perspective Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perspective Therapeutics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Perspective Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Perspective Therapeutics's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perspective Therapeutics (FRA:AAJ0) has a Market Cap of €299.44 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Perspective Therapeutics and its competitors. According to the industry distribution chart, Perspective Therapeutics ranks #314 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 36.3%.
Is Perspective Therapeutics' Market Cap too high?
Perspective Therapeutics' current Market Cap is €299.44 Mil. Based on the distribution chart, Perspective Therapeutics ranks #314 out of 866 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Perspective Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' Market Cap compare to ELMD and MASS?
According to the Medical Devices & Instruments industry distribution chart, Perspective Therapeutics ranks #314 out of 866 companies for Market Cap. This puts Perspective Therapeutics in the upper half of its industry. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Perspective Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perspective Therapeutics's current Market Cap is €299.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current Market Cap of €299.44 Mil. The current Market Cap is €299.44 Mil. Perspective Therapeutics' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current Market Cap is €299.44 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
33GF Score
Get the complete analysis for FRA:AAJ0
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AAJ0 has been successfully added to your 
